Adastra Holdings Ltd
CNSX:XTRX
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
A
|
Adastra Holdings Ltd
CNSX:XTRX
|
1.2m CAD |
Loading...
|
|
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
4.1T INR |
Loading...
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
28.2B CHF |
Loading...
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
20.7B USD |
Loading...
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
93B CNY |
Loading...
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
48.3B CNY |
Loading...
|
|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
981.5B JPY |
Loading...
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
4.3B GBP |
Loading...
|
|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
40B CNY |
Loading...
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
5.7B USD |
Loading...
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
35.9B CNY |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Adastra Holdings Ltd
Glance View
Adastra Holdings Ltd. engages in the provision of large-scale cannabis and hemp extraction technologies and provide turn-key processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company is headquartered in Langley, British Columbia. The company went IPO on 2020-01-06. The firm is a manufacturer and supplier of ethnobotanical and cannabis science products designed for the adult use and medical markets and therapeutic applications. The company is focused on its line of Phyto Extractions branded cannabis concentrate products. The firm also operates Adastra Labs, which is focused on extraction, distillation, and manufacturing of cannabis derived products. The company is a cultivator, tester, extractor, and seller of controlled substances, including Psilocybin, Psilocin, N-Dimethyltryptamine (DMT) and various others. The firm operates a multidisciplinary center for medical cannabis and psychedelic therapies, working alongside doctors and healthcare professionals through 1225140 B.C. Ltd.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Adastra Holdings Ltd is 33.2%, which is below its 3-year median of 37.6%.
Over the last 3 years, Adastra Holdings Ltd’s Gross Margin has decreased from 34.4% to 33.2%. During this period, it reached a low of 33.2% on Sep 30, 2025 and a high of 46% on Dec 31, 2022.